ROSEN TERRY J 4
4 · Arcus Biosciences, Inc. · Filed Dec 17, 2024
Insider Transaction Report
Form 4
ROSEN TERRY J
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2024-12-15$16.08/sh−37,882$609,143→ 2,369,360 total
Footnotes (2)
- [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
- [F2]This amount reflects 1,547,062 shares of the Issuer's Common Stock that are no longer beneficial owned by the Reporting Person as a result of him entering into a "domestic relations order", which change in beneficial ownership is exempt from Section 16 pursuant to Rule 16a-12 under the Securities Exchange Act of 1934, as amended.